Zoledronic and Methylphenidate hydrochloride drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Zoledronic (zoledronic acid) and Methylphenidate hydrochloride (methylphenidate hydrochloride). Common drug interactions include diarrhoea among females and basal cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Zoledronic and Methylphenidate hydrochloride. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

What is Methylphenidate hydrochloride?

Methylphenidate hydrochloride has active ingredients of methylphenidate hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 6,822 Methylphenidate hydrochloride users. Check the latest studies of Methylphenidate hydrochloride.

On Jul, 09, 2026

13 people who take Zoledronic and Methylphenidate hydrochloride together, and have interactions are studied.

Zoledronic and Methylphenidate hydrochloride drug interactions.

What are the common drug interactions of Zoledronic and Methylphenidate Hydrochloride, by gender? *:

female:

Diarrhoea
Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
Transaminases increased
Aspartate aminotransferase increased

male:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Skin cancer
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Febrile neutropenia (fever with reduced white blood cells)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the common drug interactions of Zoledronic and Methylphenidate Hydrochloride, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Diarrhoea
Gastroenteritis norovirus (inflammation of stomach and intestine caused by norovirus infection)
Transaminases increased
Aspartate aminotransferase increased

50-59:

n/a

60+:

Basal cell carcinoma (a skin cancer, it rarely metastasizes or kills)
Squamous cell carcinoma of skin (a cancer of a kind of epithelial cell, the squamous cell. these cells are the main part of the epidermis of the skin)
Skin cancer
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Febrile neutropenia (fever with reduced white blood cells)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pneumonia
Respiratory failure (inadequate gas exchange by the respiratory system)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 11 people, 84.62%
Depression: 10 people, 76.92%
Neuropathy Peripheral (surface nerve damage): 10 people, 76.92%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 10 people, 76.92%
Nausea (feeling of having an urge to vomit): 10 people, 76.92%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 9 people, 69.23%
Hyperlipidaemia (presence of excess lipids in the blood): 9 people, 69.23%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 9 people, 69.23%
Rickets (softening of bones): 9 people, 69.23%
Dementia (madness): 9 people, 69.23%

* Approximation only. Some reports may have incomplete information.

Do you take Zoledronic and Methylphenidate hydrochloride?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously